SCHEMBL7786038

SCHEMBL7786038

CC(C)(C)c1cc2ccccc2c(S(=O)(=O)O)c1S(=O)(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.49
NR1I2 O75469 1/20 0.40
ALDH1A1 P00352 4/20 0.39
HPGD P15428 2/20 0.39
MPL P40238 4/20 0.38
CYP1A2 P05177 3/20 0.38
CTRC Q99895 2/20 0.38
HIF1A Q16665 2/20 0.38
CYP2C19 P33261 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
ATIC P31939 1/20 0.38
CTRB1 P17538 1/20 0.36
TTR P02766 1/20 0.35
SUMO2 P61956 1/20 0.35
SUMO1 P63165 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP3 Q9H4L4 1/20 0.35
SENP2 Q9HC62 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16633017 0.98 CYP2D6 (0.48) CYP2D6NR1I2ALDH1A1HPGDMPL
SCHEMBL12482334 0.87 CYP2D6 (0.43) CYP2D6NR1I2ALDH1A1HPGDMPL
SCHEMBL4000559 0.87 CYP2D6 (0.47) CYP2D6NR1I2ALDH1A1HPGDMPL
SCHEMBL29996901 0.87 CYP2D6 (0.47) CYP2D6NR1I2ALDH1A1HPGDMPL
SCHEMBL5552151 0.86 CYP2D6 (0.46) CYP2D6NR1I2ALDH1A1HPGDMPL
SCHEMBL3495406 0.81 NR1I2 (0.44) CYP2D6NR1I2ALDH1A1HPGDMPL
SCHEMBL6283746 0.81 CYP2D6 (0.42) CYP2D6ALDH1A1HPGDMPLCYP1A2
SCHEMBL31398447 0.80 CYP2D6 (0.56) CYP2D6ALDH1A1HPGDMPLCYP1A2
SCHEMBL219389 0.80 CYP2D6 (0.56) CYP2D6ALDH1A1HPGDMPLCYP1A2
SCHEMBL11418053 0.80 NR1I2 (0.43) CYP2D6NR1I2ALDH1A1HPGDMPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108431017-B Salts of conjugates for cancer therapy 拜欧赛特有限公司 2021-12-21 CN disclosed
CN-111698992-A Pharmaceutical formulation for the treatment of endometriosis, uterine fibroids, polycystic ovarian syndrome or adenomyosis 艾伯维公司 2020-09-22 CN disclosed
CN-111212841-A Salt and crystal of triazolopyrazine derivative 安斯泰来制药株式会社 2020-05-29 CN disclosed
EP-0803548-B1 Colored thermoplastic resin composition ORIENT CHEMICAL IND (JP) 2001-10-24 EP disclosed
US-5827911-A BLACK DYE IS OBTAINED BY REACTION OF NIGROSINE AND ATLEAST ONE ANIONIC SURFACTANT SELECTED FROM SULFURIC ACID ESTER OR SALTS, PHSOPHORIC ACID ESTER OR SALTS, SULFONIC ACID OR SALTS AND CARBOXYLIC ACID OR SALTS ORIENT CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-27 US disclosed
EP-0803548-A2 Colored thermoplastic resin composition ORIENT CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-29 EP disclosed